Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. IJ Pharmaceutical Research
  4. Articles

  5. Celecoxib Treatment Alters p53 and MDM2 Expression via COX-2 Crosstalk in A549 Cells
  6. Scopus by Title (Ref)

IJ Pharmaceutical Research

Home
Current IssueAll IssuesIn PressAccepted Manuscripts
SearchInstructions
Journal InformationEditors & BoardsIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Exploration of the mechanism of curcumin in the regulation of apoptosis for the treatment of colorectal cancer

- Wu Y. , et al.

2. NOVEL THERAPEUTIC REGIMENS FOR URETHANE-INDUCED EARLY LUNG CANCER IN RATS: II CISPLATIN NANOPARTICLES COMBINED WITH CURCUMIN NANOPARTICLS ADJUVANT

- Mohamed N.A. , et al.

3. MiR-708 Negatively Regulates TNF α /IL-1 β Signaling by Suppressing NF- κ B and Arachidonic Acid Pathways

- Monteleone N.J. , et al.

4. Recent Developments in Celecoxib-mediated COX-2-independent NF-κB Pathway in Tumor Therapy

- Wang Y. , et al.

5. Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis

- Liu X. , et al.

6. Cytotoxic effect of 2, 5-dimethyl-celecoxib as a structural analog of celecoxib on human colorectal cancer (HT-29) cell line

- Nikanfar S. , et al.

7. Ionic liquid-assisted synthesis of celexocib using tris-(2-hydroxyethyl) ammonium acetate as an efficient and reusable catalyst

- Ahfad-Hosseini H.R. , et al.

HomeSearchInstructionsAPC

Archives

  • Current Issue
  • All Issues
  • In Press
  • Accepted Manuscripts

About Journal

  • Journal Information
  • Editors & Boards
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.